Your browser doesn't support javascript.
loading
Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.
Pareja, Fresia; Brandes, Alissa H; Basili, Thais; Selenica, Pier; Geyer, Felipe C; Fan, Dan; Da Cruz Paula, Arnaud; Kumar, Rahul; Brown, David N; Gularte-Mérida, Rodrigo; Alemar, Barbara; Bi, Rui; Lim, Raymond S; de Bruijn, Ino; Fujisawa, Sho; Gardner, Rui; Feng, Elvin; Li, Anqi; da Silva, Edaise M; Lozada, John R; Blecua, Pedro; Cohen-Gould, Leona; Jungbluth, Achim A; Rakha, Emad A; Ellis, Ian O; Edelweiss, Maria I A; Palazzo, Juan; Norton, Larry; Hollmann, Travis; Edelweiss, Marcia; Rubin, Brian P; Weigelt, Britta; Reis-Filho, Jorge S.
Afiliação
  • Pareja F; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Brandes AH; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Basili T; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Selenica P; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Geyer FC; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Fan D; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Da Cruz Paula A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Kumar R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Brown DN; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Gularte-Mérida R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Alemar B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Bi R; Genetics and Molecular Biology, Federal University of Rio Grande do Sul, Porto Alegre, 91501-970, Brazil.
  • Lim RS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • de Bruijn I; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Fujisawa S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Gardner R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Feng E; Molecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Li A; Flow Cytometry Core Facility, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • da Silva EM; Molecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Lozada JR; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Blecua P; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Cohen-Gould L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Jungbluth AA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Rakha EA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Ellis IO; Department of Biochemistry, Weill Cornell Medical College, New York, 10065, NY, USA.
  • Edelweiss MIA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Palazzo J; Department of Pathology, University of Nottingham, Nottingham, NG7 2RD, UK.
  • Norton L; Department of Pathology, University of Nottingham, Nottingham, NG7 2RD, UK.
  • Hollmann T; Hospital de Clínicas, Federal University of Rio Grande do Sul, Porto Alegre, 90035-903, Brazil.
  • Edelweiss M; Department of Pathology, Jefferson Medical College, Philadelphia, 19107, PA, USA.
  • Rubin BP; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Weigelt B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
  • Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, 10065, NY, USA.
Nat Commun ; 9(1): 3533, 2018 08 30.
Article em En | MEDLINE | ID: mdl-30166553
ABSTRACT
Granular cell tumors (GCTs) are rare tumors that can arise in multiple anatomical locations, and are characterized by abundant intracytoplasmic granules. The genetic drivers of GCTs are currently unknown. Here, we apply whole-exome sequencing and targeted sequencing analysis to reveal mutually exclusive, clonal, inactivating somatic mutations in the endosomal pH regulators ATP6AP1 or ATP6AP2 in 72% of GCTs. Silencing of these genes in vitro results in impaired vesicle acidification, redistribution of endosomal compartments, and accumulation of intracytoplasmic granules, recapitulating the cardinal phenotypic characteristics of GCTs and providing a novel genotypic-phenotypic correlation. In addition, depletion of ATP6AP1 or ATP6AP2 results in the acquisition of oncogenic properties. Our results demonstrate that inactivating mutations of ATP6AP1 and ATP6AP2 are likely oncogenic drivers of GCTs and underpin the genesis of the intracytoplasmic granules that characterize them, providing a genetic link between endosomal pH regulation and tumorigenesis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumor de Células Granulares / Receptores de Superfície Celular / ATPases Vacuolares Próton-Translocadoras / Mutação Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumor de Células Granulares / Receptores de Superfície Celular / ATPases Vacuolares Próton-Translocadoras / Mutação Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article